Market Closed -
Toronto S.E.
04:00:00 2024-06-06 pm EDT
|
5-day change
|
1st Jan Change
|
9.76
CAD
|
-8.36%
|
|
-15.79%
|
+44.38%
|
Fiscal Period: März |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Capitalization
1 |
7,154
|
15,424
|
3,737
|
1,215
|
1,062
|
811.5
|
-
|
-
|
Enterprise Value (EV)
1 |
5,643
|
14,708
|
3,866
|
1,739
|
1,456
|
1,246
|
1,329
|
811.5
|
P/E ratio
|
-5.38
x
|
-8.61
x
|
-12.3
x
|
-0.34
x
|
-1.33
x
|
-8.07
x
|
-8.99
x
|
-38
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
17.9
x
|
28.2
x
|
7.18
x
|
3.02
x
|
3.09
x
|
2.68
x
|
2.52
x
|
2.26
x
|
EV / Revenue
|
14.2
x
|
26.9
x
|
7.43
x
|
4.32
x
|
4.23
x
|
4.11
x
|
4.12
x
|
2.26
x
|
EV / EBITDA
|
-12.7
x
|
-43.2
x
|
-9.31
x
|
-4.97
x
|
-24.7
x
|
-56.9
x
|
-340
x
|
-338
x
|
EV / FCF
|
-3.82
x
|
-23.3
x
|
-6.64
x
|
-3.07
x
|
-5.1
x
|
-9.8
x
|
-18.1
x
|
41.1
x
|
FCF Yield
|
-26.2%
|
-4.28%
|
-15.1%
|
-32.6%
|
-19.6%
|
-10.2%
|
-5.53%
|
2.43%
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
34,965
|
38,216
|
39,417
|
51,264
|
91,115
|
76,198
|
-
|
-
|
Reference price
2 |
204.6
|
403.6
|
94.80
|
23.70
|
11.66
|
10.65
|
10.65
|
10.65
|
Announcement Date
|
5/29/20
|
6/1/21
|
5/27/22
|
6/22/23
|
5/30/24
|
-
|
-
|
-
|
Fiscal Period: März |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Net sales
1 |
398.8
|
546.6
|
520.3
|
402.9
|
343.9
|
303.4
|
322.5
|
358.5
|
EBITDA
1 |
-442.8
|
-340.3
|
-415.4
|
-349.7
|
-58.92
|
-21.89
|
-3.911
|
-2.398
|
EBIT
1 |
-1,046
|
-1,134
|
-713.3
|
-2,848
|
-228.7
|
-93
|
-66.76
|
-49.05
|
Operating Margin
|
-262.23%
|
-207.44%
|
-137.09%
|
-706.94%
|
-66.5%
|
-30.66%
|
-20.7%
|
-13.68%
|
Earnings before Tax (EBT)
1 |
-1,509
|
-1,684
|
-329.4
|
-3,314
|
-471.4
|
-155.6
|
-126.2
|
-111.8
|
Net income
1 |
-1,321
|
-1,745
|
-302.2
|
-3,278
|
-657.3
|
-127
|
-116
|
-55.22
|
Net margin
|
-331.35%
|
-319.2%
|
-58.08%
|
-813.63%
|
-191.1%
|
-41.88%
|
-35.96%
|
-15.4%
|
EPS
2 |
-38.00
|
-46.90
|
-7.700
|
-70.70
|
-8.790
|
-1.320
|
-1.185
|
-0.2800
|
Free Cash Flow
1 |
-1,478
|
-630.2
|
-582.5
|
-566.8
|
-285.4
|
-127.1
|
-73.46
|
19.73
|
FCF margin
|
-370.53%
|
-115.29%
|
-111.95%
|
-140.67%
|
-82.98%
|
-41.91%
|
-22.77%
|
5.5%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/29/20
|
6/1/21
|
5/27/22
|
6/22/23
|
5/30/24
|
-
|
-
|
-
|
Fiscal Period: Maart |
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 Q3
|
2025 Q4
|
2026 Q1
|
---|
Net sales
1 |
141
|
111.8
|
110.1
|
117.9
|
101.2
|
87.54
|
108.7
|
69.6
|
90.06
|
83.15
|
73.79
|
69.48
|
77.35
|
79.38
|
77.14
|
EBITDA
1 |
-67.41
|
-121.8
|
-74.8
|
-78.1
|
-87.5
|
-95.64
|
-57.84
|
-11.86
|
-8.989
|
-15.09
|
-6.154
|
-4.107
|
1.184
|
3.213
|
-3.4
|
EBIT
1 |
-150
|
-288.5
|
-110.2
|
-175.8
|
-153.8
|
-604.7
|
-87.48
|
-36.9
|
-60.32
|
-106.7
|
-25.34
|
-22.99
|
-18.26
|
-16.32
|
-
|
Operating Margin
|
-106.38%
|
-258.12%
|
-100.12%
|
-149.2%
|
-151.92%
|
-690.82%
|
-80.45%
|
-53.02%
|
-66.97%
|
-128.36%
|
-34.34%
|
-33.08%
|
-23.61%
|
-20.56%
|
-
|
Earnings before Tax (EBT)
1 |
-115.7
|
-587.1
|
-2,084
|
-223.7
|
-267.1
|
-664
|
-39.84
|
-135.3
|
-231.4
|
-96.11
|
-41.08
|
-39.19
|
-33.45
|
-30.31
|
-
|
Net income
1 |
-108.9
|
-574.6
|
-2,083
|
-221.8
|
-261.6
|
-640.1
|
-38.12
|
-310
|
-216.8
|
-82.34
|
-34.16
|
-32.37
|
-28.43
|
-22.8
|
-
|
Net margin
|
-77.27%
|
-514.11%
|
-1,891.79%
|
-188.19%
|
-258.45%
|
-731.23%
|
-35.06%
|
-445.45%
|
-240.72%
|
-99.02%
|
-46.29%
|
-46.59%
|
-36.76%
|
-28.72%
|
-
|
EPS
2 |
-2.800
|
-14.60
|
-52.30
|
-4.700
|
-5.400
|
-12.80
|
-0.7000
|
-4.300
|
-2.620
|
-1.030
|
-0.4600
|
-0.4200
|
-0.3600
|
-0.2800
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/9/22
|
5/27/22
|
8/5/22
|
11/9/22
|
2/9/23
|
6/22/23
|
8/9/23
|
11/9/23
|
2/9/24
|
5/30/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: Maart |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Net Debt
1 |
-
|
-
|
129
|
524
|
394
|
434
|
517
|
-
|
Net Cash position
1 |
1,511
|
716
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-0.3113
x
|
-1.499
x
|
-6.683
x
|
-19.84
x
|
-132.2
x
|
-
|
Free Cash Flow
1 |
-1,478
|
-630
|
-582
|
-567
|
-285
|
-127
|
-73.5
|
19.7
|
ROE (net income / shareholders' equity)
|
-21.7%
|
-27.3%
|
-8.55%
|
-151%
|
-104%
|
-26.9%
|
-10.7%
|
-5.5%
|
ROA (Net income/ Total Assets)
|
-17.1%
|
-17.2%
|
-4.86%
|
-81.5%
|
-35.1%
|
-8.8%
|
-5.4%
|
-3.4%
|
Assets
1 |
7,711
|
10,167
|
6,219
|
4,022
|
1,870
|
1,444
|
2,148
|
1,624
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
2 |
-22.20
|
-12.50
|
-
|
-12.00
|
-3.770
|
1.440
|
0.7800
|
0.1400
|
Capex
1 |
705
|
165
|
36.7
|
9.22
|
3.45
|
5.2
|
5.3
|
10.8
|
Capex / Sales
|
176.78%
|
30.09%
|
7.05%
|
2.29%
|
1%
|
1.71%
|
1.64%
|
3.01%
|
Announcement Date
|
5/29/20
|
6/1/21
|
5/27/22
|
6/22/23
|
5/30/24
|
-
|
-
|
-
|
Mean consensus UNDERPERFORM Last Close Price
9.76
CAD Average target price
8.412
CAD Spread / Average Target -13.81% Consensus |
1st Jan change
|
Capi.
|
---|
| +44.38% | 592M | | +41.52% | 6.12B | | -23.06% | 4.19B | | +11.98% | 3.43B | | -19.68% | 2.85B | | -11.52% | 2.31B | | +45.53% | 1.94B | | -8.31% | 1.55B | | +48.41% | 1.54B | | -19.16% | 1.49B |
Alternative Medicine
|